Mutation prediction and sample adequacy analyses:
Predicting molecular drivers including targetable mutations and fusions, and mapping spatial distribution of mutations from pathology tissue. Assessment of tissue adequacy for DNA and RNA NGS testing.
Custom AI Models:
IGX offers development of custom AI models tailored to the unique requirements of our clients, such as mutation detection or drug response prediction.
Image Analysis:
Our AI-powered image analysis solution can analyze whole slide images to identify and classify cancer cells, tumor margins, and other disease markers with high precision and speed.
Data Analysis:
Our data analysis platform can process large datasets from clinical trials, biobanks, and electronic health records to identify disease biomarkers, genetic variants, and drug targets.
Predictive Modeling:
Our predictive modeling solution can generate disease prognosis, treatment response, and drug efficacy predictions based on molecular data and patient characteristics.
Consulting and telepathology:
Our team of expert pathologists, data scientists, and AI engineers can provide consulting services to help healthcare organizations and biotech companies integrate AI into their pathology workflows.